Nairobi — After a stressful year working as a doctor at Kenya's largest public hospital in the midst of the Covid-19 pandemic, Ngala Mwendwa got his first dose of the AstraZeneca vaccine in March and breathed a sigh of relief.

The Indian-manufactured shot was supplied by Covax, a global vaccine initiative that has been a lifeline for poor African nations. But with India now engulfed in its own crisis, Mwendwa has no idea when he will get his second dose...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.